31 – 40 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Cognitive functioning following one-year natalizumab treatment : A non-randomized clinical trial
- Contribution to journal › Article
- 2017
-
Mark
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis : Recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
- Contribution to journal › Article
-
Mark
Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis
- Contribution to journal › Article
-
Mark
Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
- Contribution to journal › Article
- 2016
-
Mark
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo
- Contribution to journal › Article
- 2014
-
Mark
CD1d restricted NKT cells in regulation of pathogenic autoimmunity
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy.
(2012) In Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 44(1). p.87-90
- Contribution to journal › Article
-
Mark
Cost of multiple sclerosis in the Czech Republic: The COMS study
- Contribution to journal › Article
- 2011
-
Mark
MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
- Contribution to journal › Article
-
Mark
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
- Contribution to journal › Article
